Cogent Biosciences, Inc.（COGT）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Cogent Biosciences, Inc.（COGT）报告了 32 笔 Form 4 交易（最近一笔 2026-08-31）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-31 | Morris Arlene | 董事 | 买入 | 41,927 | $236,468 |
| 2026-08-31 | Morris Arlene | 董事 | 买入 | 3,583 | $9,029 |
| 2026-08-31 | Morris Arlene | 董事 | 卖出 | 42,349 | $1.6M |
| 2026-08-31 | Morris Arlene | 董事 | 卖出 | 3,161 | $118,663 |
| 2026-05-21 | Robbins Andrew R | President and CEO | 卖出 | 160,000 | $0 |
| 2026-05-21 | Robbins Andrew R | President and CEO | 买入 | 160,000 | $0 |
| 2026-03-31 | Fairmount Funds Management LLC | 董事 | 买入 | 7.0M | $0 |
| 2026-03-31 | Fairmount Funds Management LLC | 董事 | 卖出 | 7.0M | $242.6M |
| 2026-01-22 | Fairmount Funds Management LLC | 董事 | 卖出 | 3.5M | $127.4M |
| 2025-12-30 | Robinson John Edward | Chief Scientific Officer | 卖出 | 90,000 | $3.5M |
| 2025-12-30 | Sachs Jessica | Chief Medical Officer | 卖出 | 82,642 | $3.2M |
| 2025-12-30 | Green John L. | Chief Financial Officer | 卖出 | 77,000 | $3.0M |
| 2025-12-30 | Kearns Evan | Chief Legal Officer | 卖出 | 65,000 | $2.5M |
| 2025-12-19 | Robbins Andrew R | President and CEO | 买入 | 185,000 | $0 |
| 2025-12-19 | Robbins Andrew R | President and CEO | 买入 | 840,000 | $0 |
| 2025-12-19 | Robbins Andrew R | President and CEO | 卖出 | 367,497 | $14.5M |
| 2025-12-19 | Green John L. | Chief Financial Officer | 买入 | 50,000 | $0 |
| 2025-12-19 | Green John L. | Chief Financial Officer | 买入 | 300,000 | $0 |
| 2025-12-19 | Green John L. | Chief Financial Officer | 卖出 | 145,007 | $5.7M |
| 2025-12-19 | Robinson John Edward | Chief Scientific Officer | 买入 | 50,000 | $0 |
| 2025-12-19 | Robinson John Edward | Chief Scientific Officer | 买入 | 320,000 | $0 |
| 2025-12-19 | Robinson John Edward | Chief Scientific Officer | 卖出 | 139,998 | $5.5M |
| 2025-12-19 | Pinnow Cole | Chief Commercial Officer | 买入 | 50,000 | $0 |
| 2025-12-19 | Pinnow Cole | Chief Commercial Officer | 买入 | 214,000 | $0 |
| 2025-12-19 | Pinnow Cole | Chief Commercial Officer | 卖出 | 94,800 | $3.7M |
来源：SEC Form 4 申报文件 · 截至 2026-08-31